Valeant Pharmaceuticals adds prominent U.S. investor John Paulson to board
His New York-based investment firm Paulson & Co. is currently Valeant's largest shareholder, with about 5.7 per cent of the Quebec-based company's outstanding shares.
from Biotech News
0 Comments